Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - COST OF REVENUE
Cost of Revenue TRVI - Trevi Therapeutics, Inc.
123 K
LAST VALUE
56.84%
2 YEAR CAGR
39.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR